Literature DB >> 11917072

Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571.

Chagriya Kitiyakara, Vichai Atichartakarn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917072     DOI: 10.1093/ndt/17.4.685

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

2.  A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib.

Authors:  Suella Martino; Etienne Daguindau; Christophe Ferrand; Jamal Bamoulid; Sandrine Hayette; F-E Nicolini; G Capellier; Eric Deconinck; Fabrice Larosa
Journal:  Leuk Res Rep       Date:  2013-03-19

3.  Electrolyte disturbances and acute kidney injury induced by imatinib therapy.

Authors:  Rodrigo Azevedo de Oliveira; Igor Denizarde Bacelar Marques; Antonio Carlos Seguro; Lúcia Andrade
Journal:  NDT Plus       Date:  2008-12-04

4.  Minimal change disease onset observed after bevacizumab administration.

Authors:  Ramy M Hanna; Eduardo Lopez; James Wilson; Shrinath Barathan; Arthur H Cohen
Journal:  Clin Kidney J       Date:  2015-12-28

Review 5.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

6.  Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Authors:  Musa Yilmaz; Amit Lahoti; Susan O'Brien; Graciela M Nogueras-González; Jan Burger; Alessandra Ferrajoli; Gautam Borthakur; Farhad Ravandi; Sherry Pierce; Elias Jabbour; Hagop Kantarjian; Jorge E Cortes
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.